Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Malone

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|December 27, 2024
Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall SurvivalCarly M Cooke, M Ege Babadagli, Hillary Wilson, et al.
Plos One|March 10, 2021
Targeting interventions for HIV testing and treatment uptake: An attitudinal and behavioural segmentation of men aged 20-34 in KwaZulu-Natal and Mpumalanga, South AfricaJames Bell, Sunny Sharma, Shawn Malone, et al.
World Journal of Urology|October 4, 2023
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trialSoumyajit Roy, Amar U Kishan, Scott C Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADTLaurence Klotz, Chris O'Callaghan, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled TrialShawn Malone, Soumyajit Roy, Libni Eapen, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2010
Radiosurgery scope of practice in Canada: a report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committeeDavid Roberge, Cynthia Ménard, Glenn Bauman, et al.
European Urology Oncology|July 10, 2022
Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Rashid Sayyid, Fred Saad, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2012
Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRTShawn Malone, Jennifer Croke, Nicolas Roustan-Delatour, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|December 27, 2024
Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall SurvivalCarly M Cooke, M Ege Babadagli, Hillary Wilson, et al.
Plos One|March 10, 2021
Targeting interventions for HIV testing and treatment uptake: An attitudinal and behavioural segmentation of men aged 20-34 in KwaZulu-Natal and Mpumalanga, South AfricaJames Bell, Sunny Sharma, Shawn Malone, et al.
World Journal of Urology|October 4, 2023
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trialSoumyajit Roy, Amar U Kishan, Scott C Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADTLaurence Klotz, Chris O'Callaghan, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled TrialShawn Malone, Soumyajit Roy, Libni Eapen, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2010
Radiosurgery scope of practice in Canada: a report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committeeDavid Roberge, Cynthia Ménard, Glenn Bauman, et al.
European Urology Oncology|July 10, 2022
Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysisSoumyajit Roy, Rashid Sayyid, Fred Saad, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2012
Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRTShawn Malone, Jennifer Croke, Nicolas Roustan-Delatour, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2022
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancerSoumyajit Roy, Yilun Sun, Cristopher J D Wallis, et al.
Pageof 12